ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database

Role in diagnosis and clinical correlations

Stephan Kemp, Aurora Pujol, Hans R. Waterham, Björn M. Van Geel, Corinne D. Boehm, Gerald V. Raymond, Garry R Cutting, Ronald J A Wanders, Hugo W. Moser

Research output: Contribution to journalArticle

Abstract

X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene, which encodes a peroxisomal ABC half-transporter (ALDP) involved in the import of very long-chain fatty acids (VLCFA) into the peroxisome. The disease is characterized by a striking and unpredictable variation in phenotypic expression. Phenotypes include the rapidly progressive childhood cerebral form (CCALD), the milder adult form, adrenomyeloneuropathy (AMN), and variants without neurologic involvement. There is no apparent correlation between genotype and phenotype. In males, unambiguous diagnosis can be achieved by demonstration of elevated levels of VLCFA in plasma. In 15 to 20% of obligate heterozygotes, however, test results are false - negative. Therefore, mutation analysis is the only reliable method for the identification of heterozygotes. Since most X-ALD kindreds have a unique mutation, a great number of mutations have been identified in the ABCD1 gene in the last seven years. In order to catalog and facilitate the analysis of these mutations, we have established a mutation database for X-ALD (http://www.x-ald.nl). In this review we report a detailed analysis of all 406 X-ALD mutations currently included in the database. Also, we present 47 novel mutations. In addition, we review the various X-ALD phenotypes, the different diagnostic tools, and the need for extended family screening for the identification of new patients.

Original languageEnglish (US)
Pages (from-to)499-515
Number of pages17
JournalHuman Mutation
Volume18
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Adrenoleukodystrophy
Databases
Mutation
Heterozygote
Fatty Acids
Phenotype
Peroxisomes
ATP-Binding Cassette Transporters
Genetic Association Studies
Nervous System
Genes

Keywords

  • ABC
  • ABCD1
  • Addison disease
  • ALD
  • ALDP
  • Database
  • Diagnosis
  • Fatty acid
  • Peroxisomal
  • Transmembrane transporter
  • X-ALD
  • X-linked adrenoleukodystrophy

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Kemp, S., Pujol, A., Waterham, H. R., Van Geel, B. M., Boehm, C. D., Raymond, G. V., ... Moser, H. W. (2001). ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations. Human Mutation, 18(6), 499-515. https://doi.org/10.1002/humu.1227

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database : Role in diagnosis and clinical correlations. / Kemp, Stephan; Pujol, Aurora; Waterham, Hans R.; Van Geel, Björn M.; Boehm, Corinne D.; Raymond, Gerald V.; Cutting, Garry R; Wanders, Ronald J A; Moser, Hugo W.

In: Human Mutation, Vol. 18, No. 6, 2001, p. 499-515.

Research output: Contribution to journalArticle

Kemp, S, Pujol, A, Waterham, HR, Van Geel, BM, Boehm, CD, Raymond, GV, Cutting, GR, Wanders, RJA & Moser, HW 2001, 'ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations', Human Mutation, vol. 18, no. 6, pp. 499-515. https://doi.org/10.1002/humu.1227
Kemp, Stephan ; Pujol, Aurora ; Waterham, Hans R. ; Van Geel, Björn M. ; Boehm, Corinne D. ; Raymond, Gerald V. ; Cutting, Garry R ; Wanders, Ronald J A ; Moser, Hugo W. / ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database : Role in diagnosis and clinical correlations. In: Human Mutation. 2001 ; Vol. 18, No. 6. pp. 499-515.
@article{8a4b6d8c694c46eea00b0010ee9f9533,
title = "ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations",
abstract = "X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene, which encodes a peroxisomal ABC half-transporter (ALDP) involved in the import of very long-chain fatty acids (VLCFA) into the peroxisome. The disease is characterized by a striking and unpredictable variation in phenotypic expression. Phenotypes include the rapidly progressive childhood cerebral form (CCALD), the milder adult form, adrenomyeloneuropathy (AMN), and variants without neurologic involvement. There is no apparent correlation between genotype and phenotype. In males, unambiguous diagnosis can be achieved by demonstration of elevated levels of VLCFA in plasma. In 15 to 20{\%} of obligate heterozygotes, however, test results are false - negative. Therefore, mutation analysis is the only reliable method for the identification of heterozygotes. Since most X-ALD kindreds have a unique mutation, a great number of mutations have been identified in the ABCD1 gene in the last seven years. In order to catalog and facilitate the analysis of these mutations, we have established a mutation database for X-ALD (http://www.x-ald.nl). In this review we report a detailed analysis of all 406 X-ALD mutations currently included in the database. Also, we present 47 novel mutations. In addition, we review the various X-ALD phenotypes, the different diagnostic tools, and the need for extended family screening for the identification of new patients.",
keywords = "ABC, ABCD1, Addison disease, ALD, ALDP, Database, Diagnosis, Fatty acid, Peroxisomal, Transmembrane transporter, X-ALD, X-linked adrenoleukodystrophy",
author = "Stephan Kemp and Aurora Pujol and Waterham, {Hans R.} and {Van Geel}, {Bj{\"o}rn M.} and Boehm, {Corinne D.} and Raymond, {Gerald V.} and Cutting, {Garry R} and Wanders, {Ronald J A} and Moser, {Hugo W.}",
year = "2001",
doi = "10.1002/humu.1227",
language = "English (US)",
volume = "18",
pages = "499--515",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database

T2 - Role in diagnosis and clinical correlations

AU - Kemp, Stephan

AU - Pujol, Aurora

AU - Waterham, Hans R.

AU - Van Geel, Björn M.

AU - Boehm, Corinne D.

AU - Raymond, Gerald V.

AU - Cutting, Garry R

AU - Wanders, Ronald J A

AU - Moser, Hugo W.

PY - 2001

Y1 - 2001

N2 - X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene, which encodes a peroxisomal ABC half-transporter (ALDP) involved in the import of very long-chain fatty acids (VLCFA) into the peroxisome. The disease is characterized by a striking and unpredictable variation in phenotypic expression. Phenotypes include the rapidly progressive childhood cerebral form (CCALD), the milder adult form, adrenomyeloneuropathy (AMN), and variants without neurologic involvement. There is no apparent correlation between genotype and phenotype. In males, unambiguous diagnosis can be achieved by demonstration of elevated levels of VLCFA in plasma. In 15 to 20% of obligate heterozygotes, however, test results are false - negative. Therefore, mutation analysis is the only reliable method for the identification of heterozygotes. Since most X-ALD kindreds have a unique mutation, a great number of mutations have been identified in the ABCD1 gene in the last seven years. In order to catalog and facilitate the analysis of these mutations, we have established a mutation database for X-ALD (http://www.x-ald.nl). In this review we report a detailed analysis of all 406 X-ALD mutations currently included in the database. Also, we present 47 novel mutations. In addition, we review the various X-ALD phenotypes, the different diagnostic tools, and the need for extended family screening for the identification of new patients.

AB - X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene, which encodes a peroxisomal ABC half-transporter (ALDP) involved in the import of very long-chain fatty acids (VLCFA) into the peroxisome. The disease is characterized by a striking and unpredictable variation in phenotypic expression. Phenotypes include the rapidly progressive childhood cerebral form (CCALD), the milder adult form, adrenomyeloneuropathy (AMN), and variants without neurologic involvement. There is no apparent correlation between genotype and phenotype. In males, unambiguous diagnosis can be achieved by demonstration of elevated levels of VLCFA in plasma. In 15 to 20% of obligate heterozygotes, however, test results are false - negative. Therefore, mutation analysis is the only reliable method for the identification of heterozygotes. Since most X-ALD kindreds have a unique mutation, a great number of mutations have been identified in the ABCD1 gene in the last seven years. In order to catalog and facilitate the analysis of these mutations, we have established a mutation database for X-ALD (http://www.x-ald.nl). In this review we report a detailed analysis of all 406 X-ALD mutations currently included in the database. Also, we present 47 novel mutations. In addition, we review the various X-ALD phenotypes, the different diagnostic tools, and the need for extended family screening for the identification of new patients.

KW - ABC

KW - ABCD1

KW - Addison disease

KW - ALD

KW - ALDP

KW - Database

KW - Diagnosis

KW - Fatty acid

KW - Peroxisomal

KW - Transmembrane transporter

KW - X-ALD

KW - X-linked adrenoleukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=0035208916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035208916&partnerID=8YFLogxK

U2 - 10.1002/humu.1227

DO - 10.1002/humu.1227

M3 - Article

VL - 18

SP - 499

EP - 515

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 6

ER -